KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Amortizatization of Intangibles: 2024-2025

Historic Amortizatization of Intangibles for Nektar Therapeutics (NKTR) over the last 2 years, with Sep 2025 value amounting to -$1.4 million.

  • Nektar Therapeutics' Amortizatization of Intangibles rose 30.57% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year change of. This contributed to the annual value of -$9.2 million for FY2024, which is 37.77% up from last year.
  • Per Nektar Therapeutics' latest filing, its Amortizatization of Intangibles stood at -$1.4 million for Q3 2025, which was down 64.90% from -$869,000 recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Amortizatization of Intangibles peaked at -$869,000 during Q2 2025, and registered a low of -$3.1 million during Q1 2024.
  • For the 2-year period, Nektar Therapeutics' Amortizatization of Intangibles averaged around -$1.8 million, with its median value being -$1.5 million (2024).
  • Data for Nektar Therapeutics' Amortizatization of Intangibles shows a peak YoY surged of 66.37% (in 2025) over the last 5 years.
  • Over the past 2 years, Nektar Therapeutics' Amortizatization of Intangibles (Quarterly) stood at -$1.5 million in 2024, then soared by 30.57% to -$1.4 million in 2025.
  • Its Amortizatization of Intangibles was -$1.4 million in Q3 2025, compared to -$869,000 in Q2 2025 and -$1.3 million in Q1 2025.